• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    IMPLANT SUPPLY DEVICE A system for delivering an implant to a patient is revealed. Activation of the thermal coil causes the degradation, fusion or reduction of a component that leads the thermal coil into or out of electrical contact with another component, or causes the individual coil loops to count with each other, resulting in a change remarkable in resistance in the circuit that supplies the thermal coil with electricity. One with a core ends before the distal end of the device, allowing for greater flexibility.
    公开号:BR112012025969B1
    申请号:R112012025969-5
    申请日:2011-04-06
    公开日:2021-01-05
    发明作者:Heath Bowman；Jake Le；Matthew Fitz
    申请人:Microvention, Inc.；
    IPC主号:
    专利说明:

    Related requests
    [001] The present order claims priority to the provisional order US serial number 61 / 324,246 deposited on April 14, 2010 entitled “Implant delivery vice”, whose content is hereby incorporated by reference. Field of invention
    [002] The present invention relates to systems and methods for delivering implant devices to a target site or location on a patient's body. The present invention also relates to a method of detecting implant shedding in a patient's body. Background of the invention
    [003] The provision of implantable therapeutic devices through less invasive means has been shown to be desirable in numerous clinical situations. For example, vascular embolization has been used to control vascular bleeding, obstruct blood supply to tumors, obstruct fallopian tubes, and obstruct vascular aneurysms, particularly intracranial aneurysms. In recent years, vascular embolization for the treatment of aneurysms has received much attention. Implants used to treat aneurysms are often convoluted or coiled wire coils and are referred to as “microbobins”. Microbombs functional by filling an aneurysm causing the blood flow through the aneurysm to decrease or stop, thereby inducing thrombosis in the aneurysm.
    [004] Microbins are extremely flexible and have very little structural integrity. To make it easier for them to recover and reposition, recent efforts have been made to make them resistant to stretching. For example, a stretch-resistant embolic coil having a stretch-resistant element passing through the inner lumen of the coil is described in US patent no. 5,582,619 to Ken. US patent publication no. 2004/0034363 by Wilson also reveals an embolic coil with a stretch-resistant element having a distal end fixed near the distal end of the coil and a proximal end of the element fixed to a delivery catheter.
    [005] Several different treatment modalities have been employed in the prior art to use implant devices. For example, numerous repositionable detachment systems for implant devices have been described in the prior art including US patent no. 5,895,385 by Guglielmi and others and 5,108,407 by Geremia and others, the contents of which are hereby incorporated by way of reference. Various systems, such as those disclosed in US patent no. 6,500,149 to Gandhi et al. And US patent no. 4,346,712 by Handa et al., Whose contents are hereby incorporated by reference, describe the use of a heater to detach and use the implant device.
    [006] Although implant detachment and delivery systems are known in the art, they do not provide the user with feedback that the implant has actually detached from the delivery device. This is especially important in cases where the detachment is based on the application of heat or an electrolytic process where an element of time is involved. These supply devices leave the user in a position to imagine whether heat, etc., has been applied long enough to cause detachment. Consequently, there is a need for a method of detecting whether an implant has detached properly and effectively in a patient's body. Summary of the invention
    [007] The present invention is an implant delivery and delivery system used to position and use implantable devices such as coils, stents, filters and the like in a body cavity including, but not limited to, blood vessels, fallopian tubes, bad formations such as fistula and aneurysms, heart defects (for example, left atrial appendages and septal openings), and other luminal organs.
    [008] The system comprises an implant, a supply catheter (generically referred to as the supply impeller or impeller), a detachable joint to couple the plant to the impeller, a heat generating device (generically mentioned) as a heater), and a power source to apply energy to the heater.
    [009] The present invention also includes a method for detecting detachment of an implant. In particular, the detachment of an implant is detected by measuring the change in the electrical resistance of the delivery system.
    [010] The present invention can also be used in combination with the delivery mechanism disclosed in US patent application no. 11 / 212,830 deposited on August 25, 2005 entitled “Thermal detachment system for implanting devices”, which is incorporated as a reference here in its entirety.
    [011] In one aspect of the present invention, the implant is coupled to the impeller using a rope, cord, wire, wire, filament, fiber or the like. This is generically referred to as the rope. The rope may be in the form of a monofilament, rod, tape, hollow tube or similar. Many materials can be used to seamlessly attach the implant to the impeller. A class of materials are polymers such as polyolefin, polyolefin elastomer such as those made by Dow marketed under the trade name Engage or Exxon marketed under the trade name Affinity, polyethylene, polyester (PET), polyamide (Nylon), polyurethane, polypropylene, copolymer of block like PEBAX or Hytrel, and ethylene vinyl alcohol (EVA); or rubber materials such as silicone, latex and Kraton. In some cases, the polymer can also be crosslinked with radiation to manipulate its tensile strength and melting temperature. Another class of materials are metals such as titanium nickel alloy (Nitinol), gold and steel. The selection of the material depends on the material's ability to store potential energy, the melting or softening temperature, the force used for detachment, and the body's treatment site. The rope can be joined to the implant and / or the impeller by welding, knotting, brazing, bonding by adhesive, or other means known in the art. In a modality where the implant is a coil, the rope can extend through the inner lumen of the coil and be attached to the distal end of the coil. This design not only connects the implant to the impeller, but also imparts resistance to stretching the coil without the use of a secondary stretch resistant element. In other modalities where the implant is a coil, stent or filter; the load is attached to the proximal end of the implant.
    [012] In another aspect of the present invention, the rope loosely coupling the implant to the impeller acts as a reservoir of stored (that is, potential) energy that is released during loosening. This advantageously decreases the time and energy required to detach the implant because it allows the rope to be cut by applying heat without necessarily melting the material entirely. The stored energy can also exert a force on the implant that pushes it away from the delivery catheter. This separation tends to make the system safer because it can prevent the rope from solidifying again and retain the implant after loosening. Stored energy can be transmitted in several ways. In one embodiment, a spring is arranged between the implant and the impeller. The spring is compressed when the implant is attached to the impeller by joining one end of the string to one of the impeller or implant, pulling the free end of the string until the spring is at least partially compressed, then affixing the free end of the string to the other the implant or impeller. Once the two ends of the rope are restrained, potential energy in the form of tension in the rope (or compression in the spring) is stored in the system. In another embodiment, one end of the string is fixed as in the previous embodiment, and then the string is put into tension by pulling the free end of the string with a predetermined force or displacement. When the free end of the rope is then affixed, the elongation (ie, elastic deformation) of the rope material itself stores energy.
    [013] In another aspect of the present invention, a heater is arranged in or within the impeller, typically, but not necessarily, near the distal end of the impeller. The heater can be attached to the impeller by, for example, brazing, welding, adhesive bonding, mechanical bonding or other techniques known in the art. The heater may be in the form of a coiled coil, heat pipe, hollow pipe, strip, hypotube, solid bar, toroid, or similar shape. The heater can be made of a variety of materials such as steel, cobalt chromium alloy, platinum, silver, gold, tantalum, tungsten, mangalin, nickel chromium alloy available from California Fine Wire Company under the trade name Stable Ohm, conductive polymer, or similar. The rope is arranged close to the heater. The rope can pass through the lumen of a coil or hollow type heater or it can be wrapped around the heater. Although the rope can be arranged in direct contact with the heater, this is not necessary. For ease of assembly, the rope can be arranged in proximity with, but not effectively touching, the heater.
    [014] The impeller or delivery catheter is an elongated element with distal and proximal ends adapted to allow the implant to be maneuvered to the treatment site. The impeller comprises a core mandrel and one or more electrical wires to supply power to the heater. The impeller can taper in size and / or stiffness along its length, with the distal end being normally more flexible than the proximal end. In one embodiment, the impeller is adapted to be telescopically arranged in a supply conduit such as a guide catheter or microcatheter. In another embodiment, the impeller contains an internal lumen that allows it to be operated on a guide wire. In yet another embodiment, the impeller can be maneuvered directly to the treatment site without a secondary device. The impeller may have a visible radiopaque marking system with fluoroscopy that allows it to be used in combination with radiopaque markings on the microcatheter or other adjunctive devices.
    [015] In another aspect of the present invention, the core mandrel is in the form of a solid or hollow shaft, wire, tube, hypotube, coil, ribbon or combination thereof. The core chuck can be made of plastic materials like PEEK, acrylic, polyamide, polyimide, Teflon, acrylic, polyester, block copolymer like PEBAX or similar. The plastic element (s) can be selectively stiffened along the length with fibers or reinforcement wires made of metal, glass, carbon fiber, braided, coils or the like. Alternatively, or in combination with plastic components, metallic materials such as stainless steel, tungsten, cobalt chromium alloy, silver, copper, gold, platinum, titanium, titanium nickel alloy (Nitinol), and the like can be used to form the core chuck. Alternatively, or in combination with plastic and / or metallic components, ceramic components such as glass, optical fiber, zirconium or the like can be used to form the core mandrel. The core mandrel can also be a composite of materials. In one embodiment, the core mandrel comprises an inner core of radiopaque material such as platinum or tantalum and an outer cover of bend resistant material such as steel or chromium cobalt. By selectively varying the thickness of the inner core, radiopaque identifiers can be provided on the impeller without using secondary markers. In another embodiment, a core material, for example stainless steel, with desirable material properties such as bending strength and / or compressive strength is selectively covered (for example, by, coating, drawing or similar methods known in the art. ) with a low electrical resistance material such as copper, aluminum, gold or silver to increase its electrical conductivity, thereby allowing the core mandrel to be used as an electrical conductor. In another embodiment, a core material, for example, glass or optical fiber, with desirable properties such as compatibility with Magnetic Resonance Imaging (MRI), is covered with a plastic material such as PEBAX or polyimide to prevent the glass from fracturing or bending.
    [016] In another aspect of the present invention, the heater is attached to the impeller and then one or more electrical conductors are attached to the heater. In a modality, a pair of conductive wires extends substantially along the length of the impeller and the heater is attached near the distal end of the impeller and to electrical connectors near the proximal end of the impeller. In another embodiment, a conductive wire extends substantially the length of the impeller and the core mandrel itself is made of a conductive material or coated with a conductive material to act as a second electrical wire. The wire and the mandrel are coupled to the heater near the distal end and to one or more connectors near the proximal end of the impeller. In another embodiment, a bipolar conductor is coupled to the heater and is used in combination with radio frequency (RF) energy to drive the heater. In either embodiment, the conductor (s) may (s) extend parallel to the core mandrel or may pass through the inner lumen of a substantially hollow core mandrel (for example, a hypotube) .
    [017] In another aspect of the present invention, an electrical and / or thermally insulating sleeve or cover can be placed over the heater. The glove can be made of insulating materials such as polyester (PET), Teflon, block copolymer, silicone, polyimide, polyamide and the like.
    [018] In another aspect of the present invention, electrical connector (s) are arranged near the proximal end of the impeller so that the heater can be electrically connected to a power source through the conductors. In one embodiment, the connectors are in the form of a top with one or more male or female pins. In another embodiment, the connector (s) are tubes, pins, or foil that can be connected with clamp type connectors. In another embodiment, the connector (s) are tubes, pins or sheets that are adapted to match an external power source.
    [019] In another aspect of the present invention, the impeller connects to an external power source so that the heater is electrically coupled to the power source. The power source can be battery (s) or connected to the mains via a wall outlet. The power source supplies current in the form of direct current (DC), alternating current (AC), modulated direct current or radio frequency (RF) at high or low frequency. The power source can be a control box that operates outside the sterile field or it can be a portable device adapted to operate in a sterile field. The power source can be disposable, rechargeable, or it can be reusable with disposable battery (s) or rechargeable (s).
    [020] In another aspect of the present invention, the power source may comprise an electronic circuit that assists the user with detachment. In one embodiment, the circuit detects detachment from the implant and provides a signal to the user when detachment has occurred. In another mode, the circuit comprises a timer that provides a signal to the user when a pre-established period of time has elapsed. In another mode, the circuit monitors the number of detachments and provides a signal or performs an operation such as locking the system when a pre-established number of detachments has been performed. In another mode, the circuit comprises a feedback loop that monitors the number of attempts at fixation and increases the current, voltage and / or release time to increase the likelihood of a successful release.
    [021] In another aspect of the present invention, the construction of the system allows for extremely short release time. In a modality, the release time is less than 1 second.
    [022] In another aspect of the present invention, the construction of the system minimizes the surface temperature of the device during detachment. In one embodiment, the surface temperature in the heater during shedding is below 50 ° C. In another embodiment, the surface temperature in the heater during peeling is below 42 ° C.
    [023] In another aspect of the present invention, the detachment of the implant is detected by measuring a change in the electrical resistance of the delivery system, specifically the heater zone, to detect detachment of the implant.
    [024] These and other aspects and characteristics of the present invention will be recognized after consideration of the following drawings and detailed descriptions. Brief description of the drawings
    [025] Figure 1 illustrates a side view in cross section of a first embodiment of a detachment system according to the present invention; Figure 2 illustrates a cross-sectional side view of a second embodiment of a detachment system according to the present invention; Figure 3A illustrates an example continuous signal current according to the present invention; Figure 3B illustrates alternating signaling currents as an example according to the present invention; Figure 4 illustrates a cross-sectional side view of a third embodiment of a detachment system according to the present invention; Figure 5 illustrates example temperature data for the surface of a release system according to the present invention; Figure 6 shows a side cross-sectional view of an electrical connector of a detachment system according to the present invention; Figure 7 illustrates a side cross-sectional view of the radiopaque layers of a detachment system according to the present invention; and Figure 8 illustrates a cross-sectional side view of a detachment system including a stent according to the present invention; Figure 9 shows a side view of an implant device according to the present invention; Figure 10 illustrates a perspective view of a coil and spacer of the supply system of Figure 9; Figure 11 illustrates a side view of an impeller of the delivery system according to the present invention; Figure 12 shows a side view of the impeller of the supply system of Figure 11; Figure 13 shows a side view of a delivery device according to the present invention; Figure 14 shows a side view of a delivery device according to the present invention; Figure 15 shows an enlarged side view of the supply device of Figure 13; Figure 16 shows an enlarged side view of the supply device of Figure 14; and Figure 17 shows an enlarged side view of the supply device of Figure 14. Detailed description of the invention
    [026] Returning to figure 1, a detachment system 100 of the present invention and specifically the distal portion of the detachment system 100 is shown. The release system 100 includes an impeller 102 which is preferably flexible. Impeller 102 is configured for use in advancing an implant device 112 into and into a patient's body, and specifically to a target cavity site for implantation and delivery of the implant device 112. Potential target cavity sites include , but are not limited to, blood vessels and vascular sites (eg, aneurysms and fistula), openings and heart defects (eg, the left atrial appendage), and other luminal organs (eg, fallopian tubes).
    [027] A stretch-resistant rope 104 unhookily couples implant 112 to impeller 102. In this example, rope 104 is a plastic tube that attaches to impeller 102. A substantially solid cylinder could also be a design choice for the string 104. The stretch-resistant string 104 extends at least partially through the inner lumen of an implant device 112.
    [028] Near the distal end of the impeller 102, a heater 106 is arranged in proximity to the stretch-resistant rope 104. The heater 106 can be wrapped around the stretch-resistant rope 104 in such a way that the heater 106 whether exposed to or otherwise in direct contact with blood or the environment, or alternatively can be isolated by a glove, shirt, epoxy, adhesive or similar. Impeller 102 comprises a pair of electrical wires, positive electrical wire 108 and negative electrical wire 110. Wires 108 and 110 are coupled to heater 106 by any appropriate means, for example, by welding or brazing.
    [029] Electric wires 108, 110 are capable of being coupled to a source of electrical energy (not shown). As shown, the negative electric wire 110 is coupled to the distal end of the heater 106 and the positive electric wire 108 is coupled to the proximal end of the heater 106. In another embodiment, this configuration can be inverted, that is, the negative electric wire 110 it is coupled to the proximal end of the heater 106 while the positive electrical wire 108 is coupled to the distal end of the heater 106.
    [030] Energy is applied to heater 106 from electrical wires 108, 110 to cut the portion of string 104 in the vicinity of heater 106. It is not necessary for heater 106 to be in direct contact with string 104. The heater 106 must simply be in sufficient proximity to the string 104 so that heat generated by the heater 106 causes the string 104 to cut. As a result of activating the heater 106, the section of the stretch-resistant rope 104 which is approximately distal from the heater 106 and in the lumen of an implant device 112 is released from the impeller 102 together with the implant device 112.
    [031] As illustrated, implant device 112 is an embolic coil. An embolic coil suitable for use as the implant device 112 may comprise an appropriate length of wire formed in a helical microbobbin. The coil can be formed of a biocompatible material including platinum, rhodium, palladium, rhenium, tungsten, gold, silver, tantalum, and various alloys of these metals, as well as various surgical-type stainless steels. Specific materials include the platinum / tungsten alloy known as Platinum 479 (92% Pt, 8% W, available from Sigmund Cohn, Mount Vernon, NY) and nickel / titanium alloys (such as nickel / titanium alloy known as Nitinol).
    [032] Another material that can be advantageous for forming the coil is a bimetallic wire comprising a highly elastic metal with a highly radiant metal. Such bimetallic wire would also be resistant to permanent deformation. An example of such a bimetallic wire is a product comprising an outer layer of nitinol and an inner core of platinum of the pure reference type, available from Sigmund Cohn, of Mount Vernon, N.Y., and Anomet Products, of Shrewsbury, Mass.
    [033] US patent no. 6,605,101 commonly provided provides an additional description of embolic coils suitable for use as the implant device 112, including coils with primary and secondary configurations where the secondary configuration minimizes the degree of unwanted compaction of the coil after unfolding. The disclosure of US patent no. 6,605,101 is fully incorporated by reference. In addition, the implant device 112 can optionally be coated or covered with a hydrogel or a bioactive coating known in the art.
    [034] The coil-type implant device 112 resists unwinding because the stretch-resistant rope 104 that extends through the lumen of the implant device 112 requires substantially more force to deform plastically than the implant device 112 itself. stretch-resistant rope 104 therefore assists in preventing the implant device 112 from unwinding in situations in which the implant device 112 would otherwise unwind.
    [035] During assembly, potential energy can be stored in the device to facilitate detachment. In one embodiment, an optional spring 116 is placed between the heater 106 and the implant device 112. The spring is compressed during assembly and the distal end of the string 104 can be tied or attached to the distal end of the implant device. 112 or it may be fused or otherwise formed at an atraumatic distal end 114.
    [036] In one embodiment, the stretch-resistant rope 104 is made of a material such as a polyolefin, polyethylene or polypropylene elastomer. One end of string 104 is attached to impeller 102 and the free end of string 104 is pulled through implant 112 with the proximal end of implant 112 flush with heater 106 (if no spring 116 is present) or with compressed spring 116. A pre-established displacement or force is used to pre-tension the string 106, thereby storing energy in an axial orientation (ie, collateral or parallel to the long geometric axis of the impeller 102) in the string 104. The force or displacement depends on the properties of the rope material, the length of the rope 104 (which itself depends on the point of attachment of the rope to the impeller and the length of the implant). Generally, the force is below the elastic limit of the rope material, but sufficient to cause the rope to separate quickly when heat is applied. In a preferred embodiment in which the implant to be unfolded is a brain coil, the rope has a diameter in the range of approximately 0.00254 to 0.01778 cm (0.001 to 0.007 inches). Of course, the size of the rope can be changed to accommodate different types and sizes of other implants, as needed.
    [037] Turning to figure 2, another embodiment of a detachment system of the present invention, detachment system 200, is illustrated. The detachment system 200 shares several common elements with the detachment system 100. For example, the same devices usable as the implant device 112 with the detachment system 100 are also usable as the implant device 112 with the detachment system. detachment 200. These include, for example, several embolic microbobins and coils. The implant device 112 was previously described in relation to the detachment system 100. As with the implant device 112, the same identification numbers are used to identify other elements / components of the detachment system 100 that may correspond to elements / components of the release system 200. Reference is made to the description of these elements in the description of the release system 100 since that description also applies to those common elements in the release system 200.
    [038] With the detachment system 200, an interior heating element 206 is used to separate a section of a stretch-resistant tube 104 and an associated implant device 112 from the detachment system 200. The detachment system 200 includes a supply impeller 202 which incorporates a core mandrel 218. The release system 200 further includes a positive electrical wire 208 and a negative electrical wire 210 which extend through the lumen of the supply impeller 202.
    [039] To form the internal heating element 206, the positive electric wire 208 and the negative electric wire 210 can be coupled to the core mandrel 218 of the supply impeller 202. Preferably, the electric wires 208, 210 are coupled to a distal portion of core mandrel 218.
    [040] In one embodiment, the positive electrical wire 208 is coupled to a first distal location on the core wire 218, and the negative electrical wire 210 is coupled to a second distal location on the core wire 218, with the second distal location being near the first distal site. In another embodiment, the configuration is reversed, that is, the positive electrical wire 208 is coupled to the second distal location and the negative electrical wire 210 is coupled to the first distal location on the core wire 218. When the positive electrical wire 208 and negative electrical wire 210 is coupled to the distal portion of the core mandrel 218, the distal portion of the core mandrel 218 together with the electrical wires 208, 210 forms a circuit which is the inner heating element 206.
    [041] The heater 206 increases in temperature when a current is applied from an energy source (not mustard) which is coupled to the positive electrical wire 208 and the negative electrical wire 210. If a greater increase in temperature / higher degree heat is required or desired, a relatively high strength material such as platinum or tungsten can be coupled to the distal end of core chuck 218 to increase strength of core chuck 218. As a result, higher temperature increases are produced when a current is applied to the heater 206 it would be produced with a material of lower resistance. The additional relatively high strength material coupled to the distal end of the core mandrel 218 can have any suitable shape, such as, for example, a solid wire, a coil or any other shape or material as described above.
    [042] Since heater 206 is located in the lumen of the string in the shape of tube 104, heater 206 is isolated from the patient's body. As a result, the possibility of inadvertent damage to the surrounding body tissue due to heating of heater 206 can be reduced.
    [043] When a current is applied to heater 206 formed by core chuck 218, positive electrical wire 208, and negative electrical wire 210, heater 206 increases in temperature. As a result, the portion of the stretch-resistant rope 104 in proximity to the heater 206 separates and is detached, together with the implant device 112 which is coupled to the rope 104, from the detachment system 200.
    [044] In an embodiment of the detachment system 200, the proximal end of the stretch-resistant rope 104 (or the distal end of a larger tube (not shown) coupled to the proximal end of the stretch-resistant rope 104) can be extended to address size limitations and facilitate the assembly of the detachment system 200.
    [045] In a similar way to the release system 100, energy can be stored in the system with, for example, an optional compressive spring 116 or by pre-tensioning the rope 104 during assembly as previously described. When present, the release of potential energy stored in the system operates to apply additional pressure to separate the implant device 112 and the stretch-resistant portion of the string 104 to which the implant device 112 is attached, away from the heater 206 when the device implant 112 is unfolded. This advantageously decreases the required detachment time and temperature by causing the string 104 to separate and break.
    [046] As with the detachment system 100, the distal end of the stretch-resistant rope 104 of the detachment system 200 may be tied or coupled to the distal end of the implant device 112, or it may be fused or otherwise formed at an atraumatic distal end 114.
    [047] Figure 4 illustrates another preferred embodiment of a release system 300. In many respects, the release system 300 is similar to the release device 200 shown in figure 2 and the release system 100 shown in figure 1. For example, the detachment system 300 includes a delivery impeller 301 containing a heater 306 that detaches an implant device 302. The detachment system 300 also uses a rope 310 to couple the implant device 302 to the implant impeller. supply 301.
    [048] In the cross-sectional view of figure 4, a distal end of the supply impeller 301 is seen as having a coil-shaped heater 306 that is electrically coupled to electrical wires 308 and 309. These wires 308, 309 are arranged in the supply impeller 301, exiting at a proximal end of the supply impeller 301 and coupling to a power source (not shown). The rope 310 is arranged in proximity to the heater 306, having a proximal end attached to the supply impeller 301 and a distal end attached to the implant device 302. As current is applied through wires 308 and 309, the heater 306 increases in temperature until the string 310 breaks, releasing the implant device 302.
    [049] To reduce heat transfer from heater 306 to the tissue around the patient and provide electrical insulation, an insulating cover 304 is included around at least the distal end of the outer surface of the supply impeller 301. As the thickness of the 304 coating increases, the thermal insulation properties also increase. However, the increased thickness also brings increased stiffness and a larger diameter to the supply impeller 301 which could increase the difficulty of executing a supply procedure. In this way, the 304 cover is designed with a thickness that provides sufficient thermal insulation properties without excessively increasing its stiffness.
    [050] To increase the attachment of the rope 310 to the implant device 302, the implant device 302 may include a collar element 322 welded to the implant device 302 at the weld 318 and sized to fit the impeller outer circumference 312 delivery 301. The rope 310 ties around the proximal end of the implant device 302 to form the knot 316. The additional reinforcement is provided by an adhesive 314 which is arranged around the knot 316 to avoid untied or otherwise undesirable decoupling.
    [051] In a similar way as with the release systems 100 and 200, energy can be stored in the system with, for example, an optional compressive spring (similar to compressive spring 116 in figure 1, but not shown in figure 4 ) or by axially pre-tensioning the rope 104 during assembly. In this mode, one end of the rope 310 is attached close to the proximal end of the implant device 302 as previously described. The free end of the rope 310 is threaded through a distal portion of the supply impeller 301 until it reaches an exit point (not shown) of the supply impeller 301. Tension is applied to the rope 310 to store energy in the form of elastic deformation in the ma - rope material, for example, by placing a predetermined force on the free end of the rope 310 or moving the tesa rope 310 by a predetermined displacement. The free end of the rope 310 is then joined to the supply impeller 301, for example, by tying a knot, applying adhesive, or similar methods known in the art.
    [052] When present, the release of potential energy stored in the system operates to apply additional pressure to separate the implant device 302, and the portion of the string 310 to which the implant device 302 is attached, away from the heater 306 when implant device 302 is deployed. This advantageously reduces the required detachment time and temperature by causing the 310 rope to separate and break.
    [053] The present invention also provides methods of using release systems such as 100, 200 or 300 release systems. The following example refers to the use of 100, 200 or 300 release systems to obstruct brain aneurysms. It will be recognized, however, that modifying the dimensions of the detachment system 100, 200 or 300 and the component parts thereof and / or modifying the configuration of the implant device 112, 302 will allow the detachment system 100, 200 or 300 is used to treat a variety of other malformations in a body.
    [054] With this specific example, the supply impeller 102, 202 or 301 of the 100, 200 or 300 release system can be approximately 0.02540 cm to 0.07620 cm (0.010 to 0.30 inches) in diameter. The string 104, 310 that is attached near the distal end of the delivery impeller 102, 202 or 301 and is attached to the implant device 112, 302 can be 0.0005 cm to 0.0500 cm (0.0002 to 0.20 inches) in diameter. The implant device 112, 302; which can be a coil, can be approximately 0.0127 cm to 0.0500 cm (0.005 to 0.020 inches) in diameter and can be wound from 0.00127 cm to 0.0127 cm (0.0005 to 0.005 inches) of wire .
    [055] If potential energy is stored in the 100, 200 or 300 detachment system, the force used to separate the implant device 112, 302 typically varies up to 250 grams.
    [056] The supply impeller 102, 202 or 301 can comprise a core spindle 218 and at least one electrically conductive wire 108, 110, 208, 210, 308 or 309. Core spindle 218 can be used as a electrical conductor, or a pair of conductive wires can be used, or a bipolar wire can be used as previously described.
    [057] Although the detachment systems 100, 200 and 300 have been shown to provide a coil, other implant devices are considered in the present invention. For example, figure 8 illustrates the detachment system 300 as previously described in figure 4 having an implant that is a stent 390. That stent 390 could be similarly detached by a similar method as previously described with respect to detachment systems 100, 200 and 300. In an additional example, the 100, 200, or 300 detachment systems can be used to provide a filter, mesh, frame, or other medical implant suitable for delivery to a patient.
    [058] Figure 7 shows a modality of a core wire 350, which could be used in any of the modalities as a supply impeller 102, 202 or 301, which includes radiopaque materials to communicate the position of the core wire 350 for the user. Specifically, the radiopaque marker material is integrated into the 350 core yarn and varied in thickness at a desired location, making the final core yarn 350 easier and more accurate.
    [059] Previous supply impeller designs, such as those seen in US patent no. 5,895,385 for Guglielmi, are based on high density material such as gold, tantalum, tungsten, or platinum in the form of an annular band or coil. The radiopaque marker is then bonded to other less dense materials, such as stainless steel, to differentiate the radiopaque section. Since the radiopaque marker is a separate element placed at a specified distance (often approximately 3 cm) from the tip of the supply impeller, the placement must be accurate or the distal tip of the supply impeller may result in damage to the aneurysm or other complications. For example, the delivery impeller may be overextended from the microcatheter to pierce an aneurysm. In addition, the manufacturing process for making a pre-supplied impeller can be difficult and expensive, especially when connecting different materials.
    [060] The radiopaque system of the present invention overcomes these disadvantages by integrating a first radiopaque material into most of the core wire 350 while the thickness of a second radiopaque material varies, thereby eliminating the need to connect multiple sections together. As seen in figure 7, core wire 350 comprises a core mandrel 354 (ie, the first radiopaque material), preferably made of radiopaque material such as tungsten, tantalum, platinum or gold (unlike most materials radiolucent from prior art designs such as steel, Nitinol and Elgiloy).
    [061] Core wire 350 also includes a second outer layer 352, having a different radiopaque level. Preferably, the outer layer 352 is composed of a material having a lower radiopaque value than the core chuck 354, such as Elgiloy, Nitinol or stainless steel (commercially available from Fort Wayne Metals under the trade name DFT). In this respect, both the core mandrel 354 and the outer layer 352 are visible and distinguishable from each other under fluoroscopy. Outer layer 352 varies in thickness along the length of core wire 350 to provide increased flexibility and differentiation in radio density. In this way, the thicker regions of the outer layer 352 are more evident to the user than the thinner regions under fluoroscopy.
    [062] Thickness transitions of the outer layer 352 can be precisely created in desired locations with automated processes such as grinding, stretching or forging. Such automated processes eliminate the need for measurement by hand and placement of markers and additionally eliminate the need to connect a separating marker element to other radiolucent sections, thereby reducing the cost of manufacturing and complexity of the system.
    [063] In the present modality, the core wire 350 includes three main indicating regions of the outer layer 352. A proximal region 356 is the longest of the three at 137 cm, while an average region 358 is 10 cm and a distal region 360 has 3 cm. The length of each region can be determined based on the use of core wire 350. For example, the 3 cm 360 distal region can be used during a coil implantation procedure, as known in the art, allowing the user to align the edge close to the distal region 360 with a radiopaque marker on the microcatheter on which the core wire 350 is positioned. The diameter of each region depends on the application and size of the implant. For a typical cerebral aneurysm application, for example, the proximal region 356 can measure, typically 0.0127 to 0.0381 cm (0.005 to 0.015 inch), the middle region 358 can typically measure 0.00254 to 0.02032 cm ( 0.001 to 0.008 inches), while the distal 360 region can typically measure 0.00127 to 0.0254 cm (0.0005 to 0.010 inches). The core chuck 354 will typically comprise between approximately 10-80% of the total diameter of the core wire 350 at any point.
    [064] Alternatively, the core wire 350 may include any number of different regions greater than or less than three shown in figure 7. Additionally, the radiopaque material of the core chuck 354 may extend only partially through the core wire 350 For example, the radiopaque material could extend from the proximal end of the core chuck 354 to three centimeters from the distal end of the core wire 350, providing yet another predetermined position marker visible under fluoroscopy.
    [065] In this respect, regions 356, 358 and 360 of core wire 350 provide a more accurate radiopaque marking system that is easily manufactured, yet is readily evident under fluoroscopy. In addition, the increased accuracy of the markers can decrease the complications related to improper positioning of the supply impeller during a procedure.
    [066] In operation, the microcatheter is positioned on a patient so that a distal end of the microcatheter is close to a target area or lumen. Core wire 350 (in a delivery device) is inserted at the proximal end of the microcatheter and core mandrel 354 and outer layer 352 are viewed under fluoroscopy. The user aligns a radiopaque marker on the microcatheter with the beginning of the distal 360 region, which communicates the implant site 112, 302 in relation to the tip of the microcatheter.
    [067] In some situations, for example, small aneurysms where there is a high risk of damage to the vessel from the stiffness of the 350 core wire, the user can position the proximal end of the implant slightly on the distal end of the microcatheter during detachment. The user can then push the proximal end of the implant 112, 302 out of the microcatheter with the next coil, an adjunct device such as a guidewire, or the delivery device 102, 202 or 301. In another embodiment, the user can use the radiopaque marking system to locate the distal end of the supply impeller outside the distal end of the microcatheter.
    [068] After the implant device 112, 302 of the detachment system 100, 200 or 300 is placed at or around the target site, the operator can repeatedly reposition the implant device 112, 302 as necessary or desired.
    [069] When the detachment of the implant device 112, 302 at the target site is desired, the operator applies energy to the heater 106, 206 or 306 through the electrical wires 108, 110, 208, 210, 308 or 309. A A source of electrical energy for energy can be any suitable source, such as a wall outlet, a capacitor, a battery and the like. For one aspect of this method, electricity with a potential of approximately 1 volt to 100 volts is used to generate a current of 1 milliampere to 5000 milliamps, depending on the resistance of the 100, 200 or 300 release system.
    [070] A modality of a connector system 400 that can be used to electrically couple the detachment system 100, 200 or 300 to the power source is shown in figure 6. The connector system 400 includes an electrically core chuck conductive 412 having a proximal end surrounded by an insulating layer 404. Preferably, the insulating layer 404 is an insulating sleeve such as a plastic shrinkage tube of polyolefin, PET, Nylon, PEEK, Teflon, or polyimide. The insulating layer 404 can also be a coating such as polyurethane, silicone, Teflon, paraliene. An electrically conductive strip 406 is arranged on top of the insulating layer 404 and secured in place by molding strips 414, adhesive or epoxy. In this way, core chuck 412 and conductive strip 406 are electrically isolated from each other. conductive strip 406 is preferably composed of any electrically conductive material, such as silver, gold, platinum, steel, copper, conductive polymer, conductive adhesive, or similar materials, and can be a strip, coil or sheet. Gold is especially preferred as the conductive material of conductive band 406 due to the ability of the gold to be drawn into a thin wall and its ready availability. The core chuck 412 has been previously described and can be coated with, for example, gold, silver, copper or aluminum to increase its electrical conductivity.
    [071] The connector system 400 also includes two electrical wires 408 and 410 that connect to conductive band 406 and core element 412, respectively, and to a heating element at the distal end of a supply system like those described in figures 1 , 2 and 4 (not shown in figure 6). These wires 408 and 410 are preferably connected by brazing, welding, soldering, laser bonding, or conductive adhesive, or similar techniques.
    [072] After the user is ready to release the implant 112, 302 on the patient, a first electrical clamp or connector from a power source is connected to an uninsulated section 402 of core chuck 412 and a second electrical clamp or connector from the power source is connected to conductive band 406. Electrical energy is applied to the first and second electrical clamps, forming an electrical circuit in the release system 100, 200 or 300, causing the heater 106, 206 or 306 increase in temperature and separate the string 104, 310.
    [073] After the release system 100, 200 or 300 is connected to the power source, the user can apply a voltage or current as previously described. This causes heater 106, 206 or 306 to increase the temperature. When heated, the pre-tensioned rope 104, 310 will tend to recover to its untensioned (shorter) length due to heat-induced deformation. In this respect, when the string 104, 310 is heated by the heater 106, 206 or 306; its overall size shrinks. However, since each end of the string 104, 310 is held in place as previously described, the string 104, 310 is unable to shorten in length, finally breaking to release the implant device 112, 302.
    [074] As there is tension in the system already in the form of a spring 116 or deformation of the rope material 104, 310; the amount of shrinkage required to break the rope 104, 310 is less than that of a system without a pre-tensioned rope. In this way, the temperature and time required to release the implant device 112, 302 are lower.
    [075] Figure 5 is a graph showing the temperatures on the PET 304 coating surface of the peeling system 300. As can be seen, the surface temperature of the peeling system 300 during peeling does not vary linearly with the time. Specifically, it only takes less than 1 second for the heat generated by the heating coil 306 to penetrate the insulation cover 304. After 1 second, the surface temperature of the insulation cover 304 increases dramatically. Although different external insulating material may slightly increase or decrease this 1 second surface temperature window, the necessarily small diameter of the 100, 200 or 300 release system avoids providing a thick insulating layer that can more significantly delay an increase in temperature superficial.
    [076] It should be understood that the detachment system modalities 100, 200 or 300 include a variety of possible constructions. For example, the insulating cover 304 can be composed of Teflon, PET, polyamide, polyimide, silicone, polyurethane, PEEK, or materials with similar characteristics. In the 100, 200 or 300 modes, the typical thickness of the insulating cover is 0.000254 to 0.1016 cm (0.0001 to 0.040 inch). This thickness will tend to increase when the device is adapted for use in, for example, nearby malformations, and decrease when the device is adapted for use in more distal tortuous sites, such as brain aneurysms.
    [077] To minimize the damage and possible complications caused by such an increase in surface temperature, the present invention detaches the implant device 112, 302 before the surface temperature begins to increase significantly. Preferably, the implant device 112, 302 is detached in less than a second, and more preferably in less than 0.75 seconds. This prevents the surface temperature from exceeding 50 ° C (122 ° F) and more preferably exceeding 42 ° C (107 ° F).
    [078] After the user tries to detach the implant device 112, 302, it is preferably necessary to confirm that the detachment has been successful. The set of circuits integrated in the power source can be used to determine whether the detachment was successful or not. In an embodiment of the present invention, an initial signal current is provided before applying a release current (i.e., current to activate heater 106, 206, or 306 to loosen an implant 112, 302). The signaling current is used to determine the inductance in the system before the user tries to detach the implant and therefore has a lower value than the detachment current, so as not to cause premature detachment. After an attempted release, a similar signaling current is used to determine a second inductance value that is compared with the initial inductance value. A substantial difference between the initial inductance and the second inductance value indicates that the implant 112, 302 was successfully detached, while the absence of such a difference indicates unsuccessful detachment. In this regard, the user can easily determine if the implant 112, 302 has been detached, even for delivery systems that use non-conductive temperature sensitive polymers to fix an implant, such as those seen in figures 1, 2 and 4.
    [079] In the description and examples below, the terms “current” and “alternating current” are used in the most general sense and are understood to encompass alternating current (AC), direct current (DC), and radio frequency (RF) unless otherwise noted. The term “alternation” is defined as any change in current with a frequency above zero, including both high frequency and low frequency. When a value is measured, calculated and / or saved, it is understood that this can be done manually or by any known electronic method including, but not limited to, an electronic circuit, semiconductor, EPROM, computer chip, computer memory as RAM, ROM, or flash; It's similar. Finally, wire windings and toroid shapes have a wide meaning and include a variety of geometries such as circular, elliptical, spherical, quadrilateral, triangular and trapezoidal shapes.
    [080] When a changing current passes through such objects as wire windings or a toroid, it establishes a magnetic field. As the current increases or decreases, the intensity of the magnetic field increases or decreases in the same way. This fluctuation of the magnetic field causes an effect known as inductance, which tends to oppose and change further in current. Inductance (L) in a coil wrapped around a core depends on the number of turns (N), cross-sectional area of the core (A), magnetic permeability of the core (μ), and length of the coil (I) of according to equation 1 below: L = .4 π N2Aμ l Equation 1
    [081] The heater 106 or 306 is formed by a coil wound with electrically conductive wires near and distal 108, 110, 308 or 309 attached to a power source. The string 104, 310 has a magnetic permeability μ1 and is positioned through the center of the resistive heater, having a length I, cross-sectional area A and windings N, forming a core as described in the previous equation. Before shedding, a changing signal current i1, like the waveforms shown in figures 3A and 3B, with frequency f1, is sent through the coil windings. This signaling current is generally insufficient to loosen the implant. Based on the signaling current, the XCL inductive resistance (that is, the electrical resistance due to the inductance in the system) is measured by an electrical circuit such as an ohmmeter. The initial inductance of the L1 system is then calculated according to the formula: Li = XL 2π f1 Equation 2
    [082] This initial value of inductance Li depends on the magnetic permeability μ1 of the string core 104, 310 according to equation 1, and is saved for reference. When detachment is desired, a higher current and / or a current with a different frequency than the signaling current is applied through the resistive heater coil, causing the string 104, 310 to release the implant 112, 302 as before described. If the detachment is successful, the string 104, 310 will no longer be present in heater 106, 306 and the interior of heater 106, 306 will fill with another material such as the patient's blood, contrast medium, solution saline, or air. This material now inside the heater core will have a magnetic permeability μ2 that is different from the magnetic permeability of a μ1 rope core.
    [083] A second signal and frequency current f2 is sent through heater 106, 306 and is preferably the same as the first signal and frequency current, although one or both may be different without affecting the operation of the system. Based on the second signaling current, a second inductance L2 is calculated. If the detachment is successful, the second L2 inductance will be different (higher or lower) than the first L1 inductance due to the difference in μ1 and μ2 core magnetic permeabilities. If the detachment was not successful, the inductance values should remain relatively similar (with some tolerance for measurement error). After the detachment has been confirmed by comparing the difference between the two inductances, an alarm or signal can be activated to communicate successful detachment to the user. For example, the alarm could include a beep or an indicator light.
    [084] Preferably, the delivery system 100, 300 used in accordance with this invention connects to a device that automatically measures inductance at desired times, performs required calculations and signals to the user when the implant device has detached from the delivery catheter. However, it must be understood that part or all of these steps can be performed manually to achieve the same result.
    [085] The inductance between the fixed and released states can also be preferably determined without directly calculating the inductance. For example, the inductive resistance XL can be measured and compared before and after detachment. In another example, shedding can be determined by measuring and comparing the system time constant, which is the time required for the current to reach a predetermined percentage of its nominal value. Since the time constant depends on the inductance, a change in the time constant would similarly indicate a change in inductance.
    [086] The present invention can also include a feedback algorithm that is used in combination with the detecting detachment described above. For example, the algorithm automatically increases the release voltage or current automatically after the previous attempt fails to detach the implant device. This measurement cycle, attempted detachment, measurement and increased detach current / voltage continues until detachment is detected or a predetermined current or voltage limit is obtained. In this respect, a low-strength detachment could be attempted first, followed automatically by increased strength or time until detachment occurs. In this way, the battery life for a mechanism that provides the release force is increased while the average coil release time is greatly reduced.
    [087] Referring now to Figures 9 and 10, mustard is a modality of a delivery system 500 for use with the present invention that includes detachment detection capability. The supply system 500 operates on the principle that electrical current that passes through a coil held in an open, expanded gap configuration will encounter more resistance than electrical current that passes through a coil in a closed, contracted gap configuration. In the expanded configuration, the electric current must follow the total length of the coiled wire. In the contracted configuration, the electric current can join the coils and move in a longitudinal direction.
    [088] The delivery system 500 is generically similar to the previously described detachment system 300 of the present invention seen in Figure 4, including a supply impeller 301, containing a heater coil 306 that detaches an implant device 302. The delivery system Supply 500 similarly uses a rope 310 to couple implant device 302 to supply impeller 301.
    [089] The heater coil 306 is preferably a resistance heater having a plurality of turns 306A as seen in figure 10, which connects to a voltage source via a connector system at the proximal end of the supply impeller 301, as the connector system 400 described in figure 6.
    [090] The delivery system 500 also includes a heater coil expander 502 that serves two functions. First, expand the heater coil 306 in such a way that the heater coil 306 maintains a friction fit to the interior of the insulating cover 309, thereby connecting the two. Second, heater coil expander 502 expands heater coil 306 such that electricity is forced to flow around each individual turn 306A of coil 306 to maximize the strength of coil 306.
    [091] Maximizing the coil resistance not only serves to heat coil 306 when the voltage passes through, it also sets an initial value (or “normal” value) for the resistance provided by coil 306, which can be used to compare a altered resistance state, indicating detachment of the 302 implant. Consequently, the heater coil expander 502 must also be capable of being subjected to change when subjected to heat. In this regard, the heater coil expander 502 can be made of any suitable robust material capable of holding the heater coil 306 in a propelled, expanded state while also being able to melt or otherwise be reduced by heat. of the heater coil 306 to provide for the polarization of the heater coil 306 to return to an unsupported state. Examples of acceptable materials include, but are not limited to, polymers and monofilaments.
    [092] The heater coil expander 502 shown in figures 9 and 10 operates by expanding longitudinally, or radially and longitudinally, a heater coil 306 which is normally a closed gap coil in a relaxed state. In other words, the individual turns 306A contact each other when the heater coil 306 is not stretched or radially expanded. Preferably, the heater coil expander 502 may have a spiral shape, similar to heater coil 306 and as seen in figure 10. Alternatively, the heater coil expander may have a tubular, continuous shape with crystals helicals similar to the individual coil shapes of expander 502 in figure 10. It should be understood that there are a variety of different expander shapes that expand the 306A coils or coils of heater coil 306 together.
    [093] Preferably, the power source (previously described in this mode and connected to the connector system 400) also includes a measuring instrument to measure the resistance of the heater coil 306. In this respect, the power source (preferably located in a hand-sized unit) includes an indicator that communicates when a change in resistance has occurred and therefore when loosening of the implant has occurred.
    [094] An alternative embodiment of the heater coil expander 512 is shown in figures 10 and 11. The heater coil expander 512 operates in combination with heater coil 306 so that the heater turns are in a gap state open (figure 10), and a core wire 350, as previously described in figure 7, which conducts electricity. The heater coil 306 is sized to fit the core wire 350 in a contracted state. The heater coil expander 512 operates to separate heater coil 306 from core wire 350, electrically isolate heater coil 306 from there. As the heat from heater coil 306 melts or otherwise reduces or degrades heater coil expander 512, heater coil 306 restarts a contracted state (i.e., reduced diameter configuration), making electrical contact, if non-physical, with core wire 350 (figure 11). In this respect, the individual turns are shortened, significantly reducing the resistance of the circuit and thus indicating that detachment has occurred.
    [095] Another alternative embodiment of the present invention, the heater coil expander 502 can be sized to expand the heater coil 306 against the conductive reinforcement circumference 312 (shown in figure 9). Consequently, when coil 306 is in its initial expanded position, the electrically conductive reinforcement circumference 312 maintains a low initial resistance that is recorded by the controller for the circuit (ie, the power source measurement device).
    [096] When the heater coil 306 is energized, the initial resistance is noted and the heater coil expander 306 melts, degrades or otherwise reduces. The heater coil 306 then contracts, releasing the fixation tube 512 (and the rest of the implant 510) and the heater coil 522a is no longer shorted by the reinforcement circumference 312. Thus, the circuit experiences a change in resistance seen that the electric current must travel through each of the individual spines 524a. this increase in resistance means that the 302 implant is loosened.
    [097] Figures 14, 16 and 17 illustrate another preferred embodiment of a delivery impeller 600 according to the present invention that includes a more flexible distal tip than some of the previously described embodiments. Figures 13 and 15 illustrate views of the previously described supply impeller 301 which are provided throughout the figures of the supply impeller 600 for comparison purposes.
    [098] The core wire 350 of the supply impeller 301, as seen in figures 13 and 15, ends near the proximal end of the heater coil 306 at the distal end of the supply impeller 301. In this respect, the distal end of the delivery impeller 301 maintains a moderate amount of stiffness to advance in a vascular system while allowing sufficient flexibility to advance through tortuous pathways and into a treatment site (for example, an aneurysm).
    [099] While the combination of flexibility and stiffness may be desirable in some treatment sites, other treatment sites would benefit from greater flexibility in the distal end of the treatment device 301. For example, in some locations, a microcatheter can be positioned in an aneurysm however when implant 302 and delivery device 301 are advanced into the microcatheter (ie, push out implant 302), delivery device 302 may, in some situations, “kick out ”Or push the microcatheter out of the aneurysm. In another example, the transition in stiffness between the portion of the delivery device including the core wire 350 and the distal region without the core wire 350 can, in some situations, provide a tactile sensation to the physician that could be mistaken for the microcatheter being kicked out of the aneurysm.
    [0100] The delivery device 600 is generally softer and more flexible than the delivery device 301 at the distal end (for example, 3 cm from the distal end) by terminating the core wire 602 at a location closer than that of the delivery device 301. For example, core wire 602 ends near the 3 cm radiopaque marker (location 604 in figure 14) which is 3 cm from the distal end of device 600 (for example, the distal portion of sleeve 304) . In contrast, the core wire 350 terminates at a location 351 near the proximal end of the heater coil 306 (figure 13). Core wire 602 may also preferably terminate between approximately 2 cm and 4 cm from the distal end of device 600 (for example, the distal end of sleeve 304).
    [0101] A support coil 313 is located around at least some elements of device 600, such as string 310 and connects to heater coil 306. Support coil 313 can include different coil densities or frequencies, such as the densely wound central region and two less dense end regions as seen in figure 14. Since core wire 601 is a primary contributing factor to the rigidity of the delivery device 600, the distal end of the delivery device 600 it is more flexible, being mainly supported by the support coil 313.
    [0102] This increased flexibility allows less “recoil” or opposite movement of the microcatheter as the delivery device 600 advances distally within it, and therefore reduces the likelihood of the microcatheter being pushed out of an aneurysm or injury .
    [0103] In addition, a longer or greater number of implants (for example, as microbobins) can be used in an aneurysm or injury. More specifically, as an aneurysm is filled with occluding microbobins, the areas in the aneurysm that can support the position of the microcatheter decrease. As a result, as an aneurysm is filled, it can be difficult to prevent the distal end of the microcatheter from being pushed out by the advancing forces of the delivery device. However, the softer distal tip of the delivery device 600 provides less “recoil” force in the microcatheter and therefore allows the aneurysm to be filled to a greater capacity.
    [0104] The supply device 600 further includes an insulated electrical wire 308 terminating at a location 311 near a distal end of the heater coil 306 and up to an electrically conductive strip at a proximal end of the supply device 600 (similar to arrangement shown in figure 6). In this respect, the insulation of wire 308 prevents electrical communication with core wire 602.
    [0105] A bare or uninsulated wire 608 terminates at a location 11 near the proximal end of the heater coil 306. Wire 608 is welded to core wire 602 at a first location near the proximal end of core wire 602 (similar to the arrangement shown in figure 6) and to a second location 606 near the termination point of core wire 604.
    [0106] Preferably, wire 608 is composed of a material that conducts electricity with little resistance, such as 99.99% silver, and has a diameter of approximately 0.00508 cm (0.002 inches). By providing an additional solder point 606 to core wire 602, additional current charged by core wire 602 is reduced to zero. In comparison, the core wire 350 of the delivery device 301 can, in some situations, charge as much as 40 mA. Consequently, electricity is more efficiently conveyed to heater coil 306 on supply device 600 and can thereby provide more focused heat around heater coil 306, allowing for improved detachment performance.
    [0107] Additionally, using a bare, non-insulated wire 608 the manufacturing process for the delivery device 600 can be made more secure. For example, firo 608 does not require extraction of an insulating coating (for example, a polyimide coating) at multiple locations. This extraction can result in damage or thinning of the wire, which can increase manufacturing costs.
    [0108] In operation, the connector system 400 is connected to a power source to selectively supply energy to release an implant. When supplied, electricity passes to the proximal end of the core wire 602, to the proximal end of the uninsulated wire 608, beyond the solder point 606, to the distal end of the heater coil 306 at point 611, through the coil heater 306 and into the distal end of the insulated wire 308 at point 311, through the extension of the wire 308 and terminating in the electrically conductive strip on the connector system 400. Alternatively, electricity could take the reverse path.
    [0109] Although the invention has been described in terms of specific modalities and applications, a person with common knowledge in the art, in the light of this teaching, can generate additional modalities and modifications without departing from the spirit of or exceeding the scope of the claimed invention. For example, the heater coil or heater coil expander could be built to activate a switch that provides an indication to the user of detachment in some way. In addition, a visual indicator can be associated with the change in resistance to provide easy indication of detachment. Therefore, it should be understood that the drawings and descriptions of the present invention are given as an example to facilitate understanding of the invention and should not be construed as limiting the scope of the invention.
    权利要求:
    Claims (5)
    [0001]
    1. Delivery device (600), CHARACTERIZED by the fact that it comprises: an elongated tubular element (304); an implant retention mechanism (310) located in said tubular element and releasably fixing an implant at a distal end of said tubular element (304); a core wire (602) to reinforce said elongated tubular element; said core wire (602) at least partially located in said tubular member; said core wire (602) having a distal end that ends between 2 cm and 4 cm proximally to said distal end of said tubular element; an electrical connector (400) located at a proximal end of said device (600) and a heater coil (306) located at said distal end of said tubular element (304); a non-insulated wire (608) electrically connected to said core wire (602) at a first and second location, and still connected to said heater coil (306).
    [0002]
    Supply device according to claim 1, CHARACTERIZED by the fact that said distal end of said core wire (602) terminates 3 cm from said distal end of said tubular element (304).
    [0003]
    Supply device according to claim 1, CHARACTERIZED by the fact that said heater coil (306) is separated from said core wire (602).
    [0004]
    4. Supply device, according to claim 1, CHARACTERIZED by the fact that it also comprises an insulated wire (308) connected to said electrical connector and heater coil.
    [0005]
    5. Delivery device according to claim 1, CHARACTERIZED by the fact that it further comprises a support coil (313) located between said distal end of said tubular element (304) and said distal end of said wire core (602).
    类似技术:
    公开号 | 公开日 | 专利标题
    US20210161539A1|2021-06-03|MicroVention, Inc.
    US20200093495A1|2020-03-26|Implant Delivery Device
    US8460332B2|2013-06-11|System and method of detecting implant detachment
    US20210204959A1|2021-07-08|Implant Delivery System
    US20060200192A1|2006-09-07|Thermal detachment system for implantable devices
    AU2008340276A1|2009-07-02|System and method for locating detachment zone of a detachable implant
    同族专利:
    公开号 | 公开日
    CN103037776A|2013-04-10|
    CA2795740A1|2011-10-20|
    JP5899200B2|2016-04-06|
    US20170100126A1|2017-04-13|
    CN103037776B|2017-07-04|
    JP2013523391A|2013-06-17|
    EP2558000A4|2015-10-21|
    WO2011130081A1|2011-10-20|
    US10517604B2|2019-12-31|
    CA2795740C|2018-03-13|
    AU2011240927A1|2012-11-08|
    US20110301686A1|2011-12-08|
    AU2011240927B2|2015-07-16|
    US20200093495A1|2020-03-26|
    EP2558000A1|2013-02-20|
    EP2558000B1|2019-09-04|
    US9561125B2|2017-02-07|
    BR112012025969A2|2017-11-21|
    KR20130054952A|2013-05-27|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    USRE32348E|1976-04-29|1987-02-10|Miniature balloon catheter method and apparatus|
    US4346712A|1979-04-06|1982-08-31|Kuraray Company, Ltd.|Releasable balloon catheter|
    JPS6030225B2|1979-09-14|1985-07-15|Kuraray Co|
    HU184722B|1980-02-18|1984-10-29|Laszlo Lazar|Therapeutically suitable silicone rubber mixture and therapeuticaid|
    US4364392A|1980-12-04|1982-12-21|Wisconsin Alumni Research Foundation|Detachable balloon catheter|
    US4545367A|1982-07-16|1985-10-08|Cordis Corporation|Detachable balloon catheter and method of use|
    US4638803A|1982-09-30|1987-01-27|Rand Robert W|Medical apparatus for inducing scar tissue formation in a body|
    US4512338A|1983-01-25|1985-04-23|Balko Alexander B|Process for restoring patency to body vessels|
    US4735201A|1986-01-30|1988-04-05|The Beth Israel Hospital Association|Optical fiber with detachable metallic tip for intravascular laser coagulation of arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas|
    US4795741A|1987-05-06|1989-01-03|Biomatrix, Inc.|Compositions for therapeutic percutaneous embolization and the use thereof|
    US4819637A|1987-09-01|1989-04-11|Interventional Therapeutics Corporation|System for artificial vessel embolization and devices for use therewith|
    JPH0410831B2|1988-03-18|1992-02-26|
    JPH0510954B2|1988-03-18|1993-02-12|Tokai Rika Denki Seisakusho Kk|
    US4994069A|1988-11-02|1991-02-19|Target Therapeutics|Vaso-occlusion coil and method|
    US5155336A|1990-01-19|1992-10-13|Applied Materials, Inc.|Rapid thermal heating apparatus and method|
    US6425893B1|1990-03-13|2002-07-30|The Regents Of The University Of California|Method and apparatus for fast electrolytic detachment of an implant|
    US5976131A|1990-03-13|1999-11-02|The Regents Of The University At California|Detachable endovascular occlusion device activated by alternating electric current|
    US5354295A|1990-03-13|1994-10-11|Target Therapeutics, Inc.|In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas|
    US5569245A|1990-03-13|1996-10-29|The Regents Of The University Of California|Detachable endovascular occlusion device activated by alternating electric current|
    US5122136A|1990-03-13|1992-06-16|The Regents Of The University Of California|Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas|
    US5851206A|1990-03-13|1998-12-22|The Regents Of The University Of California|Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment|
    US5147317A|1990-06-04|1992-09-15|C.R. Bard, Inc.|Low friction varied radiopacity guidewire|
    US5108407A|1990-06-08|1992-04-28|Rush-Presbyterian St. Luke's Medical Center|Method and apparatus for placement of an embolic coil|
    US5163952A|1990-09-14|1992-11-17|Michael Froix|Expandable polymeric stent with memory and delivery apparatus and method|
    US5133731A|1990-11-09|1992-07-28|Catheter Research, Inc.|Embolus supply system and method|
    DE4104702C2|1991-02-15|1996-01-18|Malte Neuss|Implants for organ pathways in spiral form|
    US5217484A|1991-06-07|1993-06-08|Marks Michael P|Retractable-wire catheter device and method|
    US5147370A|1991-06-12|1992-09-15|Mcnamara Thomas O|Nitinol stent for hollow body conduits|
    US5304194A|1991-10-02|1994-04-19|Target Therapeutics|Vasoocclusion coil with attached fibrous element|
    US5226911A|1991-10-02|1993-07-13|Target Therapeutics|Vasoocclusion coil with attached fibrous element|
    US5242452A|1991-10-11|1993-09-07|Kanji Inoue|Device for collapsing an appliance collapsible for insertion into human organs|
    US5256146A|1991-10-11|1993-10-26|W. D. Ensminger|Vascular catheterization system with catheter anchoring feature|
    JP3356447B2|1991-10-16|2002-12-16|テルモ株式会社|Vascular lesion embolic material composed of dried polymer gel|
    US5261916A|1991-12-12|1993-11-16|Target Therapeutics|Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling|
    US5258042A|1991-12-16|1993-11-02|Henry Ford Health System|Intravascular hydrogel implant|
    DE69324239T2|1992-01-21|1999-11-04|Univ Minnesota|SEPTUAL DAMAGE CLOSURE DEVICE|
    US5469867A|1992-09-02|1995-11-28|Landec Corporation|Cast-in place thermoplastic channel occluder|
    US5443478A|1992-09-02|1995-08-22|Board Of Regents, The University Of Texas System|Multi-element intravascular occlusion device|
    US5312415A|1992-09-22|1994-05-17|Target Therapeutics, Inc.|Assembly for placement of embolic coils using frictional placement|
    IL106946D0|1992-09-22|1993-12-28|Target Therapeutics Inc|Detachable embolic coil assembly|
    US5250071A|1992-09-22|1993-10-05|Target Therapeutics, Inc.|Detachable embolic coil assembly using interlocking clasps and method of use|
    US5382259A|1992-10-26|1995-01-17|Target Therapeutics, Inc.|Vasoocclusion coil with attached tubular woven or braided fibrous covering|
    US5382260A|1992-10-30|1995-01-17|Interventional Therapeutics Corp.|Embolization device and apparatus including an introducer cartridge and method for delivering the same|
    US5350397A|1992-11-13|1994-09-27|Target Therapeutics, Inc.|Axially detachable embolic coil assembly|
    US5690666A|1992-11-18|1997-11-25|Target Therapeutics, Inc.|Ultrasoft embolism coils and process for using them|
    US5443454A|1992-12-09|1995-08-22|Terumo Kabushiki Kaisha|Catheter for embolectomy|
    US5423849A|1993-01-15|1995-06-13|Target Therapeutics, Inc.|Vasoocclusion device containing radiopaque fibers|
    EP0681456A4|1993-01-27|1996-08-07|Instent Inc|Vascular and coronary stents.|
    US5334201A|1993-03-12|1994-08-02|Cowan Kevin P|Permanent stent made of a cross linkable material|
    NL9300500A|1993-03-22|1994-10-17|Industrial Res Bv|Expandable hollow sleeve for locally supporting and / or strengthening a body vessel, as well as a method for manufacturing it.|
    AU686613B2|1993-03-23|1998-02-12|Focal, Inc.|Apparatus and method for local application of polymeric material to tissue|
    IL109169A|1993-03-30|1999-06-20|Instent Inc|Temporary stent system|
    US5334210A|1993-04-09|1994-08-02|Cook Incorporated|Vascular occlusion assembly|
    US5925059A|1993-04-19|1999-07-20|Target Therapeutics, Inc.|Detachable embolic coil assembly|
    US5800453A|1993-04-19|1998-09-01|Target Therapeutics, Inc.|Detachable embolic coil assembly using interlocking hooks and slots|
    US5498227A|1993-09-15|1996-03-12|Mawad; Michel E.|Retrievable, shielded radiotherapy implant|
    US5443495A|1993-09-17|1995-08-22|Scimed Lifesystems Inc.|Polymerization angioplasty balloon implant device|
    EP0721546B1|1993-09-25|1998-12-02|KSB Aktiengesellschaft|Turbo-machine with reduced attrition|
    US5423777A|1993-10-27|1995-06-13|Tajiri; Akira|Punctum plug|
    US5624449A|1993-11-03|1997-04-29|Target Therapeutics|Electrolytically severable joint for endovascular embolic devices|
    US5423829A|1993-11-03|1995-06-13|Target Therapeutics, Inc.|Electrolytically severable joint for endovascular embolic devices|
    JP2880070B2|1994-03-31|1999-04-05|株式会社カネカメディックス|Medical wire having an indwelling member|
    JP3466620B2|1994-04-07|2003-11-17|デリオ・メディカル・インスツルメンツ・リミテッド|Device for removing obstruction in pipe|
    JP2535785B2|1994-06-03|1996-09-18|工業技術院長|Vascular embolic agent|
    US5549624A|1994-06-24|1996-08-27|Target Therapeutics, Inc.|Fibered vasooclusion coils|
    US5725546A|1994-06-24|1998-03-10|Target Therapeutics, Inc.|Detachable microcoil delivery catheter|
    US5522836A|1994-06-27|1996-06-04|Target Therapeutics, Inc.|Electrolytically severable coil assembly with movable detachment point|
    JPH10504738A|1994-07-08|1998-05-12|マイクロベナコーポレイション|Medical device forming method and vascular embolization device|
    US5690671A|1994-12-13|1997-11-25|Micro Interventional Systems, Inc.|Embolic elements and methods and apparatus for their delivery|
    US5814062A|1994-12-22|1998-09-29|Target Therapeutics, Inc.|Implant delivery assembly with expandable coupling/decoupling mechanism|
    US5578074A|1994-12-22|1996-11-26|Target Therapeutics, Inc.|Implant delivery method and assembly|
    IL116561D0|1994-12-30|1996-03-31|Target Therapeutics Inc|Severable joint for detachable devices placed within the body|
    US5614204A|1995-01-23|1997-03-25|The Regents Of The University Of California|Angiographic vascular occlusion agents and a method for hemostatic occlusion|
    US5634936A|1995-02-06|1997-06-03|Scimed Life Systems, Inc.|Device for closing a septal defect|
    DE69624525T2|1995-03-30|2003-03-20|Boston Scient Ltd|System for implanting liquid spirals with a secondary structure|
    US5676671A|1995-04-12|1997-10-14|Inoue; Kanji|Device for introducing an appliance to be implanted into a catheter|
    US5645558A|1995-04-20|1997-07-08|Medical University Of South Carolina|Anatomically shaped vasoocclusive device and method of making the same|
    US5639277A|1995-04-28|1997-06-17|Target Therapeutics, Inc.|Embolic coils with offset helical and twisted helical shapes|
    WO1996036297A1|1995-05-19|1996-11-21|Kanji Inoue|Transplantation instrument, method of bending same and method of transplanting same|
    US5722989A|1995-05-22|1998-03-03|The Regents Of The University Of California|Microminiaturized minimally invasive intravascular micro-mechanical systems powered and controlled via fiber-optic cable|
    US6312407B1|1995-06-05|2001-11-06|Medtronic Percusurge, Inc.|Occlusion of a vessel|
    US5624461A|1995-06-06|1997-04-29|Target Therapeutics, Inc.|Three dimensional in-filling vaso-occlusive coils|
    NO962336L|1995-06-06|1996-12-09|Target Therapeutics Inc|Vaso-occlusive spiral|
    US5591199A|1995-06-07|1997-01-07|Porter; Christopher H.|Curable fiber composite stent and delivery system|
    US6705323B1|1995-06-07|2004-03-16|Conceptus, Inc.|Contraceptive transcervical fallopian tube occlusion devices and methods|
    US5725568A|1995-06-27|1998-03-10|Scimed Life Systems, Inc.|Method and device for recanalizing and grafting arteries|
    US5582619A|1995-06-30|1996-12-10|Target Therapeutics, Inc.|Stretch resistant vaso-occlusive coils|
    US6013084A|1995-06-30|2000-01-11|Target Therapeutics, Inc.|Stretch resistant vaso-occlusive coils |
    US5743905A|1995-07-07|1998-04-28|Target Therapeutics, Inc.|Partially insulated occlusion device|
    US5580568A|1995-07-27|1996-12-03|Micro Therapeutics, Inc.|Cellulose diacetate compositions for use in embolizing blood vessels|
    US5667767A|1995-07-27|1997-09-16|Micro Therapeutics, Inc.|Compositions for use in embolizing blood vessels|
    US5601600A|1995-09-08|1997-02-11|Conceptus, Inc.|Endoluminal coil delivery system having a mechanical release mechanism|
    US5658308A|1995-12-04|1997-08-19|Target Therapeutics, Inc.|Bioactive occlusion coil|
    US5749894A|1996-01-18|1998-05-12|Target Therapeutics, Inc.|Aneurysm closure method|
    US5702361A|1996-01-31|1997-12-30|Micro Therapeutics, Inc.|Method for embolizing blood vessels|
    US6270495B1|1996-02-22|2001-08-07|Radiotherapeutics Corporation|Method and device for enhancing vessel occlusion|
    US5792154A|1996-04-10|1998-08-11|Target Therapeutics, Inc.|Soft-ended fibered micro vaso-occlusive devices|
    JP4014226B2|1996-06-20|2007-11-28|ヴァスキュテックリミテッド|Repair of the body's path by prosthesis|
    US5902254A|1996-07-29|1999-05-11|The Nemours Foundation|Cathether guidewire|
    US5823198A|1996-07-31|1998-10-20|Micro Therapeutics, Inc.|Method and apparatus for intravasculer embolization|
    JP3784112B2|1996-08-15|2006-06-07|株式会社カネカメディックス|Coiled embolic material|
    US5964797A|1996-08-30|1999-10-12|Target Therapeutics, Inc.|Electrolytically deployable braided vaso-occlusion device|
    JP3754145B2|1996-09-20|2006-03-08|株式会社カネカメディックス|Medical wire having in-vivo indwelling member|
    US5690667A|1996-09-26|1997-11-25|Target Therapeutics|Vasoocclusion coil having a polymer tip|
    US5830178A|1996-10-11|1998-11-03|Micro Therapeutics, Inc.|Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide|
    US5846247A|1996-11-15|1998-12-08|Unsworth; John D.|Shape memory tubular deployment system|
    US5733329A|1996-12-30|1998-03-31|Target Therapeutics, Inc.|Vaso-occlusive coil with conical end|
    US5911737A|1997-02-28|1999-06-15|The Regents Of The University Of California|Microfabricated therapeutic actuators|
    US5830230A|1997-03-07|1998-11-03|Micro Therapeutics, Inc.|Method of intracranial vascular embolotherapy using self anchoring coils|
    WO1998040033A2|1997-03-12|1998-09-17|Cardiosynopsis, Inc.|In situ formed stent|
    US5800454A|1997-03-17|1998-09-01|Sarcos, Inc.|Catheter deliverable coiled wire thromboginic apparatus and method|
    US5944733A|1997-07-14|1999-08-31|Target Therapeutics, Inc.|Controlled detachable vasoocclusive member using mechanical junction and friction-enhancing member|
    US5984929A|1997-08-29|1999-11-16|Target Therapeutics, Inc.|Fast detaching electronically isolated implant|
    EP0948935B1|1997-10-30|2007-09-05|Kaneka Medix Corporation|Medical implement for depositing implantable device|
    US6159165A|1997-12-05|2000-12-12|Micrus Corporation|Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand|
    US5935145A|1998-02-13|1999-08-10|Target Therapeutics, Inc.|Vaso-occlusive device with attached polymeric materials|
    US5941888A|1998-02-18|1999-08-24|Target Therapeutics, Inc.|Vaso-occlusive member assembly with multiple detaching points|
    US6015424A|1998-04-28|2000-01-18|Microvention, Inc.|Apparatus and method for vascular embolization|
    US6511492B1|1998-05-01|2003-01-28|Microvention, Inc.|Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders|
    US6293960B1|1998-05-22|2001-09-25|Micrus Corporation|Catheter with shape memory polymer distal tip for deployment of therapeutic devices|
    US6500149B2|1998-08-31|2002-12-31|Deepak Gandhi|Apparatus for deployment of micro-coil using a catheter|
    US6224610B1|1998-08-31|2001-05-01|Micrus Corporation|Shape memory polymer intravascular delivery system with heat transfer medium|
    US6277126B1|1998-10-05|2001-08-21|Cordis Neurovascular Inc.|Heated vascular occlusion coil development system|
    US20060241682A1|2003-12-08|2006-10-26|Kurz Daniel R|Intravascular device push wire delivery system|
    US6383204B1|1998-12-15|2002-05-07|Micrus Corporation|Variable stiffness coil for vasoocclusive devices|
    US6835185B2|1998-12-21|2004-12-28|Micrus Corporation|Intravascular device deployment mechanism incorporating mechanical detachment|
    US6296622B1|1998-12-21|2001-10-02|Micrus Corporation|Endoluminal device delivery system using axially recovering shape memory material|
    US6478773B1|1998-12-21|2002-11-12|Micrus Corporation|Apparatus for deployment of micro-coil using a catheter|
    US6086599A|1999-02-08|2000-07-11|The Regents Of The University Of California|Micro devices using shape memory polymer patches for mated connections|
    US6221066B1|1999-03-09|2001-04-24|Micrus Corporation|Shape memory segmented detachable coil|
    WO2000066211A1|1999-04-30|2000-11-09|Usaminanotechnology, Inc.|Catheter and guide wire|
    US6290673B1|1999-05-20|2001-09-18|Conor Medsystems, Inc.|Expandable medical device delivery system and method|
    AU5179900A|1999-06-02|2000-12-18|Sethel Interventional, Inc.|Intracorporeal occlusive device|
    US6375668B1|1999-06-02|2002-04-23|Hanson S. Gifford|Devices and methods for treating vascular malformations|
    US6238403B1|1999-10-04|2001-05-29|Microvention, Inc.|Filamentous embolic device with expansible elements|
    US6602261B2|1999-10-04|2003-08-05|Microvention, Inc.|Filamentous embolic device with expansile elements|
    AU2002344223B2|2001-05-29|2006-07-06|Microvention, Inc.|Method of manufacturing expansile filamentous embolization devices|
    US6589227B2|2000-01-28|2003-07-08|William Cook Europe Aps|Endovascular medical device with plurality of wires|
    US7033374B2|2000-09-26|2006-04-25|Microvention, Inc.|Microcoil vaso-occlusive device with multi-axis secondary configuration|
    US6740073B1|2000-12-06|2004-05-25|Advanced Cardiovascular Systems, Inc.|Guiding catheter reinforcement with angled distal end|
    WO2002055146A1|2001-01-09|2002-07-18|Microvention, Inc.|Embolectomy catheters and method for treatment|
    US6602269B2|2001-03-30|2003-08-05|Scimed Life Systems|Embolic devices capable of in-situ reinforcement|
    US6716238B2|2001-05-10|2004-04-06|Scimed Life Systems, Inc.|Stent with detachable tethers and method of using same|
    US6454780B1|2001-06-21|2002-09-24|Scimed Life Systems, Inc.|Aneurysm neck obstruction device|
    US7011671B2|2001-07-18|2006-03-14|Atritech, Inc.|Cardiac implant device tether system and method|
    WO2003022344A2|2001-09-06|2003-03-20|Nmt Medical, Inc.|Flexible delivery system|
    US7048719B1|2002-06-07|2006-05-23|Microvention, Inc.|Endovascular catheter resheathing apparatus and related methods|
    US7485122B2|2002-06-27|2009-02-03|Boston Scientific Scimed, Inc.|Integrated anchor coil in stretch-resistant vaso-occlusive coils|
    US7608058B2|2002-07-23|2009-10-27|Micrus Corporation|Stretch resistant therapeutic device|
    US20050171572A1|2002-07-31|2005-08-04|Microvention, Inc.|Multi-layer coaxial vaso-occlusive device|
    US6807446B2|2002-09-03|2004-10-19|Celsion Corporation|Monopole phased array thermotherapy applicator for deep tumor therapy|
    US7001422B2|2002-09-23|2006-02-21|Cordis Neurovascular, Inc|Expandable stent and delivery system|
    WO2004062509A1|2003-01-10|2004-07-29|Kaneka Corporation|Embolus forming in-vivo indwelling implant|
    JP2004261234A|2003-02-20|2004-09-24|Kaneka Medix Corp|Internal indwelling device for forming embolus|
    US7651513B2|2003-04-03|2010-01-26|Boston Scientific Scimed, Inc.|Flexible embolic device delivery system|
    EP1689482A1|2003-10-28|2006-08-16|Peacock, James C., III|Embolic filter device and related systems and methods|
    US20050149108A1|2003-12-17|2005-07-07|Microvention, Inc.|Implant delivery and detachment system and method|
    US7918872B2|2004-07-30|2011-04-05|Codman & Shurtleff, Inc.|Embolic device delivery system with retractable partially coiled-fiber release|
    WO2006024040A2|2004-08-25|2006-03-02|Microvention, Inc.|Thermal detachment system for implantable devices|
    US7335113B2|2004-11-17|2008-02-26|Callaway Golf Company|Golf club with interchangeable head-shaft connection|
    US20060271097A1|2005-05-31|2006-11-30|Kamal Ramzipoor|Electrolytically detachable implantable devices|
    US7371251B2|2005-06-02|2008-05-13|Cordis Neurovascular, Inc.|Stretch resistant embolic coil delivery system with mechanical release mechanism|
    US7708754B2|2005-06-02|2010-05-04|Codman & Shurtleff, Pc|Stretch resistant embolic coil delivery system with mechanical release mechanism|
    US20060276826A1|2005-06-02|2006-12-07|Vladimir Mitelberg|Stretch resistant embolic coil delivery system with mechanical release mechanism|
    US7367987B2|2005-06-02|2008-05-06|Cordis Neurovascular, Inc.|Stretch resistant embolic coil delivery system with mechanical release mechanism|
    US7708755B2|2005-06-02|2010-05-04|Codman & Shurtleff Inc.|Stretch resistant embolic coil delivery system with combined mechanical and pressure release mechanism|
    US7811305B2|2005-06-02|2010-10-12|Codman & Shurtleff, Inc.|Stretch resistant embolic coil delivery system with spring release mechanism|
    US9636115B2|2005-06-14|2017-05-02|Stryker Corporation|Vaso-occlusive delivery device with kink resistant, flexible distal end|
    US7628797B2|2006-01-31|2009-12-08|Edwards Lifesciences Corporation|System, apparatus, and method for fastening tissue|
    US7344558B2|2006-02-28|2008-03-18|Cordis Development Corporation|Embolic device delivery system|
    US8998926B2|2006-04-06|2015-04-07|DePuy Synthes Products, LLC|Heat detachable coil|
    US20080039743A1|2006-08-09|2008-02-14|Coherex Medical, Inc.|Methods for determining characteristics of an internal tissue opening|
    US8795316B2|2007-04-25|2014-08-05|DePuy Syntheses Products, LLC|Implantable medical device delivery system with a frangible portion and methods of making and using the same|
    US20080283066A1|2007-05-17|2008-11-20|Cardiac Pacemakers, Inc.|Delivery device for implantable sensors|
    WO2008144587A2|2007-05-18|2008-11-27|Boston Scientific Scimed, Inc.|Medical implant detachment systems|
    US8328841B2|2007-05-22|2012-12-11|Cook Medical Technologies Llc|Embolization coil delivery systems and methods|
    CA2692962C|2007-07-27|2016-09-13|Microvention, Inc.|Detachable coil incorporating stretch resistance|
    WO2009082716A1|2007-12-21|2009-07-02|Microvention, Inc.|System and method for locating detachment zone of a detachable implant|
    AU2008345596B2|2007-12-21|2013-09-05|Microvention, Inc.|A system and method of detecting implant detachment|
    EP2240093B1|2008-01-04|2013-04-24|Boston Scientific Scimed, Inc.|Detachment mechanisms for implantable devices|
    CA2739603A1|2008-10-13|2010-04-22|Stryker Corporation|Vaso-occlusive coil delivery system|
    US20100160944A1|2008-12-24|2010-06-24|Boston Scientific Scimed, Inc.|Thermally detachable embolic assemblies|
    US9968358B2|2009-04-15|2018-05-15|Microvention, Inc.|Implant delivery system|
    KR101719831B1|2009-04-15|2017-03-24|마이크로벤션, 인코포레이티드|Implant delivery system|
    JP5515981B2|2009-08-20|2014-06-11|日油株式会社|Asphalt adhesion inhibitor composition|
    CN104487024B|2012-03-16|2017-08-29|微仙美国有限公司|Support and support delivery device|US8425549B2|2002-07-23|2013-04-23|Reverse Medical Corporation|Systems and methods for removing obstructive matter from body lumens and treating vascular defects|
    WO2006127005A1|2005-05-25|2006-11-30|Chestnut Medical Technologies, Inc.|System and method for delivering and deploying and occluding device within a vessel|
    US8267985B2|2005-05-25|2012-09-18|Tyco Healthcare Group Lp|System and method for delivering and deploying an occluding device within a vessel|
    KR101334502B1|2005-10-19|2013-12-05|펄사 배스큘러, 아이엔씨.|Method and systems for endovascularly clipping and repairing lumen and tissue defects|
    WO2007121405A2|2006-04-17|2007-10-25|Micro Therapeutics, Inc.|System and method for mechanically positioning intravascular implants|
    US8777979B2|2006-04-17|2014-07-15|Covidien Lp|System and method for mechanically positioning intravascular implants|
    US9220522B2|2007-10-17|2015-12-29|Covidien Lp|Embolus removal systems with baskets|
    US9198687B2|2007-10-17|2015-12-01|Covidien Lp|Acute stroke revascularization/recanalization systems processes and products thereby|
    US8088140B2|2008-05-19|2012-01-03|Mindframe, Inc.|Blood flow restorative and embolus removal methods|
    US8585713B2|2007-10-17|2013-11-19|Covidien Lp|Expandable tip assembly for thrombus management|
    US8926680B2|2007-11-12|2015-01-06|Covidien Lp|Aneurysm neck bridging processes with revascularization systems methods and products thereby|
    US8066757B2|2007-10-17|2011-11-29|Mindframe, Inc.|Blood flow restoration and thrombus management methods|
    US10123803B2|2007-10-17|2018-11-13|Covidien Lp|Methods of managing neurovascular obstructions|
    KR101819554B1|2008-02-22|2018-01-17|마이크로 테라퓨틱스 인코포레이티드|Methods and apparatus for flow restoration|
    EP2271390A4|2008-04-11|2016-07-20|Covidien Lp|Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby|
    EP2387959B1|2008-04-21|2013-11-13|Covidien LP|Braid-ball embolic devices and delivery systems|
    US9675482B2|2008-05-13|2017-06-13|Covidien Lp|Braid implant delivery systems|
    US9402707B2|2008-07-22|2016-08-02|Neuravi Limited|Clot capture systems and associated methods|
    JP2011528943A|2008-07-22|2011-12-01|マイクロセラピューティクス，インコーポレイテッド|Blood vessel remodeling device|
    WO2010028314A1|2008-09-05|2010-03-11|Pulsar Vascular, Inc.|Systems and methods for supporting or occluding a physiological opening or cavity|
    US20110202085A1|2009-11-09|2011-08-18|Siddharth Loganathan|Braid Ball Embolic Device Features|
    US9814562B2|2009-11-09|2017-11-14|Covidien Lp|Interference-relief type delivery detachment systems|
    CN102770091B|2010-01-28|2015-07-08|泰科保健集团有限合伙公司|Vascular remodeling device|
    WO2011094638A1|2010-01-28|2011-08-04|Micro Therapeutics, Inc.|Vascular remodeling device|
    ES2683943T3|2010-10-22|2018-09-28|Neuravi Limited|Clot capture and removal system|
    US8721571B2|2010-11-22|2014-05-13|Siwa Corporation|Selective removal of cells having accumulated agents|
    JP5868432B2|2011-02-11|2016-02-24|コヴィディエン リミテッド パートナーシップ|Two-stage deployed aneurysm embolization device|
    US9301769B2|2011-03-09|2016-04-05|Neuravi Limited|Clot retrieval device for removing clot from a blood vessel|
    US11259824B2|2011-03-09|2022-03-01|Neuravi Limited|Clot retrieval device for removing occlusive clot from a blood vessel|
    US9089332B2|2011-03-25|2015-07-28|Covidien Lp|Vascular remodeling device|
    US8795313B2|2011-09-29|2014-08-05|Covidien Lp|Device detachment systems with indicators|
    US8945171B2|2011-09-29|2015-02-03|Covidien Lp|Delivery system for implantable devices|
    US9060886B2|2011-09-29|2015-06-23|Covidien Lp|Vascular remodeling device|
    US9579104B2|2011-11-30|2017-02-28|Covidien Lp|Positioning and detaching implants|
    US9358370B2|2012-03-12|2016-06-07|Medtronic Vascular, Inc.|Guidewire with integral radiopaque markers|
    US8932318B2|2012-03-30|2015-01-13|DePuy Synthes Products, LLC|Embolic coil detachment mechanism with polymer tether|
    US9155540B2|2012-03-30|2015-10-13|DePuy Synthes Products, Inc.|Embolic coil detachment mechanism with heating element and kicker|
    US9155647B2|2012-07-18|2015-10-13|Covidien Lp|Methods and apparatus for luminal stenting|
    US9314248B2|2012-11-06|2016-04-19|Covidien Lp|Multi-pivot thrombectomy device|
    US9295571B2|2013-01-17|2016-03-29|Covidien Lp|Methods and apparatus for luminal stenting|
    US10561509B2|2013-03-13|2020-02-18|DePuy Synthes Products, Inc.|Braided stent with expansion ring and method of delivery|
    US10603157B2|2013-03-13|2020-03-31|DePuy Synthes Products, Inc.|Braid implant delivery and retraction device with distal engagement|
    EP3536252A3|2013-03-14|2019-10-23|Neuravi Limited|A clot retrieval device for removing occlusive clot from a blood vessel|
    EP2967611B1|2013-03-14|2019-01-16|Neuravi Limited|Devices for removal of acute blockages from blood vessels|
    US9463105B2|2013-03-14|2016-10-11|Covidien Lp|Methods and apparatus for luminal stenting|
    WO2014144980A1|2013-03-15|2014-09-18|Covidien Lp|Occlusive device|
    CN110169802A|2013-03-15|2019-08-27|柯惠有限合伙公司|The conveying of Vascular implant and separating mechanism|
    EP2818202B1|2013-06-24|2016-04-13|Sorin CRM SAS|Coupling system between a medical device and an accessory for in situ implantation thereof|
    EP2818201B1|2013-06-24|2016-07-20|Sorin CRM SAS|Intracardiac capsule and accessory for in situ implantation by the femoral route|
    US10232144B2|2013-12-20|2019-03-19|Microvention, Inc.|Electrically-responsive hydrogels|
    US9265512B2|2013-12-23|2016-02-23|Silk Road Medical, Inc.|Transcarotid neurovascular catheter|
    US11065019B1|2015-02-04|2021-07-20|Route 92 Medical, Inc.|Aspiration catheter systems and methods of use|
    US11076860B2|2014-03-31|2021-08-03|DePuy Synthes Products, Inc.|Aneurysm occlusion device|
    US11154302B2|2014-03-31|2021-10-26|DePuy Synthes Products, Inc.|Aneurysm occlusion device|
    US10265086B2|2014-06-30|2019-04-23|Neuravi Limited|System for removing a clot from a blood vessel|
    US9918718B2|2014-08-08|2018-03-20|DePuy Synthes Products, Inc.|Embolic coil delivery system with retractable mechanical release mechanism|
    US10206796B2|2014-08-27|2019-02-19|DePuy Synthes Products, Inc.|Multi-strand implant with enhanced radiopacity|
    US9855050B2|2014-09-19|2018-01-02|DePuy Synthes Products, Inc.|Vasculature occlusion device detachment system with tapered corewire and single loop fuse detachment|
    US9782178B2|2014-09-19|2017-10-10|DePuy Synthes Products, Inc.|Vasculature occlusion device detachment system with tapered corewire and heater activated fiber detachment|
    US11253278B2|2014-11-26|2022-02-22|Neuravi Limited|Clot retrieval system for removing occlusive clot from a blood vessel|
    CN107405159A|2015-02-04|2017-11-28|92号医疗公司|Quick aspirate thrombi removes system and method|
    US9375333B1|2015-03-06|2016-06-28|Covidien Lp|Implantable device detachment systems and associated devices and methods|
    WO2017019563A1|2015-07-24|2017-02-02|Route 92 Medical, Inc.|Anchoring delivery system and methods|
    US20170071615A1|2015-09-15|2017-03-16|Cook Medical Technologies Llc|Method and device for improving passage of electrohydraulic lithotripsy probe|
    JP6938471B2|2015-09-18|2021-09-22|マイクロベンション インコーポレイテッドＭｉｃｒｏｖｅｎｔｉｏｎ， Ｉｎｃ．|Implant retention, separation and pressing system|
    US10478194B2|2015-09-23|2019-11-19|Covidien Lp|Occlusive devices|
    AU2017218115B2|2016-02-10|2020-03-05|Microvention, Inc.|Devices for vascular occlusion|
    CN113368367A|2016-02-24|2021-09-10|禾木（中国）生物工程有限公司|Neurovascular catheter with enhanced flexibility|
    EP3457954A4|2016-05-18|2020-01-08|Microvention, Inc.|Embolic containment|
    US10881868B2|2016-05-24|2021-01-05|Sorin Crm Sas|Torque limiting mechanism between a medical device and its implantation accessory|
    US10285710B2|2016-06-01|2019-05-14|DePuy Synthes Products, Inc.|Endovascular detachment system with flexible distal end and heater activated detachment|
    EP3912569A4|2016-06-10|2021-11-24|Terumo Corp|Vessel occluder|
    US10076428B2|2016-08-25|2018-09-18|DePuy Synthes Products, Inc.|Expansion ring for a braided stent|
    AU2017324233A1|2016-09-06|2019-04-04|Neuravi Limited|A clot retrieval device for removing occlusive clot from a blood vessel|
    US10292851B2|2016-09-30|2019-05-21|DePuy Synthes Products, Inc.|Self-expanding device delivery apparatus with dual function bump|
    CN110381855A|2017-01-06|2019-10-25|因赛普特有限责任公司|Anti-thrombogenic coatings for aneurysm treatment device|
    AU2018208460A1|2017-01-10|2019-07-25|Route 92 Medical, Inc.|Aspiration catheter systems and methods of use|
    US10905853B2|2017-01-17|2021-02-02|DePuy Synthes Products, Inc.|System and method for delivering a catheter|
    US10881497B2|2017-01-26|2021-01-05|DePuy Synthes Products, Inc.|Composite vascular flow diverter|
    US10751066B2|2017-02-23|2020-08-25|DePuy Synthes Products, Inc.|Aneurysm device and delivery system|
    EP3629945A4|2017-05-25|2021-03-03|Terumo Corporation|Adhesive occlusion systems|
    US10874402B2|2017-10-10|2020-12-29|Boston Scientific Scimed, Inc.|Detachable RF energized occlusive device|
    US11039840B2|2017-12-11|2021-06-22|Microvention, Inc.|Implant detachment|
    US10806462B2|2017-12-21|2020-10-20|DePuy Synthes Products, Inc.|Implantable medical device detachment system with split tube and cylindrical coupling|
    US10751065B2|2017-12-22|2020-08-25|DePuy Synthes Products, Inc.|Aneurysm device and delivery system|
    US10905430B2|2018-01-24|2021-02-02|DePuy Synthes Products, Inc.|Aneurysm device and delivery system|
    US10918390B2|2018-03-30|2021-02-16|DePuy Synthes Products, Inc.|Helical balloon assist device and method for using the same|
    US10806461B2|2018-04-27|2020-10-20|DePuy Synthes Products, Inc.|Implantable medical device detachment system with split tube|
    WO2019212984A1|2018-05-01|2019-11-07|Imperative Care, Inc.|Devices and methods for removing obstructive material from an intravascular site|
    CN112423824A|2018-05-17|2021-02-26|92号医疗公司|Aspiration catheter system and method of use|
    US11058430B2|2018-05-25|2021-07-13|DePuy Synthes Products, Inc.|Aneurysm device and delivery system|
    US10939915B2|2018-05-31|2021-03-09|DePuy Synthes Products, Inc.|Aneurysm device and delivery system|
    US10667833B2|2018-06-08|2020-06-02|Neuravi Limited|Guidewire with an atraumatic clot-circumventing configured distal end for use in an endovascular medical system|
    US10898216B2|2018-06-13|2021-01-26|DePuy Synthes Products, Inc.|Vasculature obstruction capture device|
    AU2019204522A1|2018-07-30|2020-02-13|DePuy Synthes Products, Inc.|Systems and methods of manufacturing and using an expansion ring|
    US10905431B2|2018-08-03|2021-02-02|DePuy Synthes Products, Inc.|Spiral delivery system for embolic braid|
    US10278848B1|2018-08-06|2019-05-07|DePuy Synthes Products, Inc.|Stent delivery with expansion assisting delivery wire|
    US11051825B2|2018-08-08|2021-07-06|DePuy Synthes Products, Inc.|Delivery system for embolic braid|
    US10813780B2|2018-08-08|2020-10-27|DePuy Synthes Products, Inc.|Intraluminal implant delivery system and method|
    US10842498B2|2018-09-13|2020-11-24|Neuravi Limited|Systems and methods of restoring perfusion to a vessel|
    US11123077B2|2018-09-25|2021-09-21|DePuy Synthes Products, Inc.|Intrasaccular device positioning and deployment system|
    US11253287B2|2018-10-04|2022-02-22|Neuravi Limited|Retrograde blood flow occlusion flushing device|
    US11076861B2|2018-10-12|2021-08-03|DePuy Synthes Products, Inc.|Folded aneurysm treatment device and delivery method|
    US11147562B2|2018-12-12|2021-10-19|DePuy Synthes Products, Inc.|Systems and methods for embolic implant detachment|
    US11039944B2|2018-12-27|2021-06-22|DePuy Synthes Products, Inc.|Braided stent system with one or more expansion rings|
    US11134953B2|2019-02-06|2021-10-05|DePuy Synthes Products, Inc.|Adhesive cover occluding device for aneurysm treatment|
    US11185334B2|2019-03-28|2021-11-30|DePuy Synthes Products, Inc.|Single lumen reduced profile occlusion balloon catheter|
    US11051928B2|2019-04-11|2021-07-06|Neuravi Limited|Floating carotid filter|
    US10653425B1|2019-05-21|2020-05-19|DePuy Synthes Products, Inc.|Layered braided aneurysm treatment device|
    US11109939B2|2019-06-14|2021-09-07|DePuy Synthes Products, Inc.|Intravascular devices with radiopaque body markers|
    US11253265B2|2019-06-18|2022-02-22|DePuy Synthes Products, Inc.|Pull wire detachment for intravascular devices|
    US11207494B2|2019-07-03|2021-12-28|DePuy Synthes Products, Inc.|Medical device delivery member with flexible stretch resistant distal portion|
    US11266426B2|2019-07-10|2022-03-08|DePuy Synthes Products, Inc.|Streamlined treatment of clot removal, angioplasty and prevention of restenosis using a single integrated intravascular device|
    US11266427B2|2019-07-10|2022-03-08|Neuravi Limited|Self-expanding intravascular medical device|
    CN113347916A|2019-10-15|2021-09-03|因普瑞缇夫护理公司|System and method for multivariate stroke detection|
    CN113365687A|2019-12-18|2021-09-07|因普瑞缇夫护理公司|Method and system for treating venous thromboembolic disorders|
    US11207497B1|2020-08-11|2021-12-28|Imperative Care, Inc.|Catheter with enhanced tensile strength|
    法律状态:
    2018-12-26| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|
    2019-08-13| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|
    2020-02-27| B07A| Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]|
    2020-06-23| B06A| Patent application procedure suspended [chapter 6.1 patent gazette]|
    2020-10-13| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|
    2021-01-05| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/04/2011, OBSERVADAS AS CONDICOES LEGAIS. |
    优先权:
    申请号 | 申请日 | 专利标题
    US32424610P| true| 2010-04-14|2010-04-14|
    US61/324,246|2010-04-14|
    PCT/US2011/031434|WO2011130081A1|2010-04-14|2011-04-06|Implant delivery device|
    [返回顶部]